Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk

被引:0
|
作者
Le Marchand, L [1 ]
Donlon, T [1 ]
Seifried, A [1 ]
Wilkens, LR [1 ]
机构
[1] Univ Hawaii, Canc Res Ctr Hawaii, Etiol Program, Honolulu, HI 96813 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
N-Nitroso compounds are suspected colorectal cancer (CRC) carcinogens to which individuals on a diet high in red meat (RM) may be particularly exposed. Many of these compounds undergo alpha-hydroxylation by CYP2E1 to form DNA adducts. The gene coding for this enzyme is polymorphic and thus may constitute a susceptibility factor for CRC. We conducted a population-based case-control study in Hawaii to test the association of two functional polymorphisms in CYP2E1 (the G1259C RsaI substitution and a 5' 96-bp insertion variant) with CRC, as well as their modifying effects on the association of RM and processed meat (PM) with this cancer. We obtained interviews and blood samples for 521 patients with CRC (165 with rectal cancer) and 639 controls of Japanese, Caucasian, or Hawaiian origin. Genotyping was performed by PCR. After adjustment for CRC risk factors, subjects with the 5' insert variant were found to be at a 60% increased risk (95% confidence interval, 1.1-2.5) for rectal cancer. Subjects who carry the insert and who were predicted to have been exposed to increased levels of nitrosamines, based on their high intake of RM or PM, were at a markedly greater increased risk (2- and 3-fold for RM and PM, respectively) for rectal cancer. No clear association was found for colon cancer. A similar increase in rectal cancer risk was found for CYP2E1 insert carriers who consumed salted/dried fish or Oriental pickled vegetables. These data provide additional support for the hypothesis that nitrosamines are carcinogenic to the rectum in humans and that RM and, in particular, PMs are significant sources of exposure for these compounds.
引用
收藏
页码:1019 / 1024
页数:6
相关论文
共 50 条
  • [1] Red meat intake, CYP2E1 and PPARγ polymorphisms, and colorectal cancer risk
    Kim, Na-Hui
    Seol, Ju Eun
    Kim, Jeongseon
    Lee, Bong-Hwa
    Hwang, Dae-Yong
    Jeong, Jinyoung
    Lee, Hun-Jae
    Ahn, Yoon-Ok
    Kim, Dong-Hyun
    Lee, Jung Eun
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2019, 28 (04) : 304 - 310
  • [2] Genetic Polymorphisms of CYP2E1 and Risk of Colorectal Cancer: The Fukuoka Colorectal Cancer Study
    Morita, Makiko
    Le Marchand, Loic
    Kono, Suminori
    Yin, Guang
    Toyomura, Kengo
    Nagano, Jun
    Mizoue, Tetsuya
    Mibu, Ryuichi
    Tanaka, Masao
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    Okamura, Takeshi
    Ikejiri, Koji
    Futami, Kitaroh
    Maekawa, Takafumi
    Yasunami, Yohichi
    Takenaka, Kenji
    Ichimiya, Hitoshi
    Imaizumi, Nobutoshi
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (01) : 235 - 241
  • [3] CYP2E1 RSAI AND 96-BP INSERTION GENETIC POLYMORPHISMS AND RISK OF COLORECTAL CANCER
    Silva, Tiago
    Felipe, Aledson
    Barao, Katia
    Forones, Nora
    ANNALS OF ONCOLOGY, 2011, 22 : v113 - v113
  • [4] CYP2E1 RsaI and 96-bp insertion genetic polymorphisms associated with risk for colorectal cancer
    Silva, T. D.
    Felipe, A. V.
    Pimenta, C. A. M.
    Barao, K.
    Forones, N. M.
    GENETICS AND MOLECULAR RESEARCH, 2012, 11 (03) : 3138 - 3145
  • [5] CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan
    Hildesheim, A
    Anderson, LM
    Chen, CJ
    Cheng, YJ
    Brinton, LA
    Daly, AK
    Reed, CD
    Chen, IH
    Caporaso, NE
    Hsu, MM
    Chen, JY
    Idle, JR
    Hoover, RN
    Yang, CS
    Chhabra, SK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (16): : 1207 - 1212
  • [6] Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study
    Morita, Makiko
    Tabata, Shinji
    Tajima, Osamu
    Yin, Guang
    Abe, Hiroshi
    Kono, Suminori
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (07) : 1800 - 1807
  • [7] CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis
    Jiang, Ou
    Zhou, Rongxing
    Wu, Daoquan
    Liu, Yu
    Wu, Wenjian
    Cheng, Nansheng
    TUMOR BIOLOGY, 2013, 34 (02) : 1215 - 1224
  • [8] LUNG-CANCER SUSCEPTIBILITY AND GENETIC POLYMORPHISMS IN THE CYP2E1 GENE
    LAW, JC
    SCHWARTZ, AG
    SIEGFRIED, JM
    HUNT, JD
    FERRELL, RE
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 319 - 319
  • [9] Association between CYP2E1 genetic polymorphisms and urinary cancer risk: a meta-analysis
    Fang, Zhiqing
    Wu, Yun
    Zhang, Ning
    ONCOTARGET, 2017, 8 (49) : 86853 - 86864
  • [10] Association between CYP2E1 genetic polymorphisms and lung cancer risk: A meta-analysis
    Wang, Yadong
    Yang, Haiyan
    Li, Li
    Wang, Haiyu
    Zhang, Congke
    Yin, Gongju
    Zhu, Baoyu
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) : 758 - 764